Website intended for a NZ health professional readership
The Medicines Regulations 1984 is your guide to supplying patients with generic meds, writes Auckland pharmacy law lecturer Sanya Ram
1.Regulation 42(4) of the Medicines Regulations 1984
2. Right 7 (1) The HDC Code of Health and Disability Services Consumers' Rights Regulation 1996
3.Rights 6(1) (b) The HDC Code of Health and Disability Services Consumers' Rights Regulation 1996
4. BPAC. 2009. What is bioavailability and bioequivalence? Best Practice Journal: Special Edition Generics 4-8. URL: www.bpac.org.nz/magazine/2009/generics/docs/bpjse_generics_2009.pdf (accessed 29 June 2019)
5.Generic Medicines and Bioequivalence Prescriber Update 34(1):8-9
March 2013 https://medsafe.govt.nz/profs/PUArticles/Mar2013GenericMedBioqueivalence.htm (Accessed 1 July 2019)
6.Medicines Adverse Reactions Committee Report, Brand Switches in New Zealand, September 2018, URL: https://medsafe.govt.nz/committees/marc/reports/175-Brand%20Switches%20in%20New%20Zealand.pdf (Accessed 1 July 2019)
7.FDA. Approved Drug Products with Therapeutic Equivalence Evaluations. 28th ed. 2008. www.fda.gov/cder/orange/obannual.pdf. Accessed 1 July 2019.
This article, written by Sidhesh Phaldessai, provides an overview of geriatric psychopharmacology, including the epidemiology of mental health disorders in the older population, the physiological changes that occur with ageing and their impact on pharmacokinetics and pharmacodynamics, and the use of psychotropic medications in older adults
Current clinical guidelines emphasise the significance of having two Adrenaline Auto-Injectors (AAIs) for individuals at risk of anaphylaxis.1*
